FDA Has Awarded 6 Additional National Priority Vouchers

Marty Makary, 27th Commissioner of the U.S. FDA, shared a post on X by FDA, adding:

“Beautiful teamwork. We’re rewarding companies that bring pharmaceutical manufacturing back to the U.S., address public health needs in new ways, and lower prices for Americans.”

Quoting FDA’s post:

“FDA has awarded 6 additional National Priority Vouchers. The latest recipients tackle major health challenges: HER2 lung cancer, drug-resistant TB in children, rectal cancer, sickle cell disease, and obesity. When companies commit to accessibility and national priorities, we commit to speed.”

Read further.

More posts featuring Marty Makary on OncoDaily.